Skip to content
Gian Lifecare logo

Gian Lifecare

542918 BSE
₹4.25

Close ·

P/E
Not meaningful: loss-making over the last twelve months
View as Markdown
MCP
Close 4 Nov 2026 ₹4.25 −7.82 −64.8% 1Y
Start ₹12.07

Key Fundamentals

MicrocapHealthcare ServicesHealthcare

Price-based figures at the close · EPS basis: Consolidated · TTM

ROCE
2.40%
Debt to Equity
0.31
EPS (TTM)
−₹0.92
Book Value
₹18.15
Market Cap
—
P/E (TTM)
Not meaningful: loss-making over the last twelve months
P/B
0.23
ROE
−0.21%
Dividend Yield
0.00%
EBITDA
₹1.20 Cr
52W High
₹13.23
52W Low
₹3.93

Tapetide Score

Data-driven rating, 0–100, as of . How it works →

Overall score

36 Poor

Data confidence 91/100

Category scores

Quality
48
Average
Returns, margins, earnings quality 22% weight
Valuation
53
Average
Cheap vs sector & own history 24% weight
Growth
1
Poor
Sales & profit trajectory 9% weight
Financial Health
27
Poor
Solvency, leverage, coverage 9% weight
Momentum
12
Poor
Trend strength, vol-adjusted 12% weight
Ownership
40
Weak
FII/DII/promoter flows 24% weight

The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.

Key Insights

Strengths

1
  • Stock is trading at 0.25 times its book value

Weaknesses

6
  • Company has low interest coverage ratio.
  • Promoter holding has decreased over last quarter: -1.92%
  • Promoter holding is low: 30.2%
  • Company has a low return on equity of 10.1% over last 3 years.
  • Promoters have pledged 65.1% of their holding.
  • Company has high debtors of 374 days.

Technical Indicators

Technical signals: verdict and indicator counts
GroupSignalBearishNeutralBullish
OverallStrong Bearish1063
OscillatorsBullish162
Moving AveragesStrong Bearish901

Key readings

RSI (14)
43.36
Neutral
MACD (12,26,9)
−0.11
Bullish
SMA (50)
4.57
Bearish
SMA (200)
6.14
Bearish

As of

Growth Rate

From the financial statements below. 3Y: compound annual growth to Mar 2025; 1Y: fiscal year to Mar 2025 against Mar 2024; TTM: four quarters to Dec 2025 against Dec 2024.

Revenue

Revenue growth by window
3Y−27.29%
1Y−53.52%
TTM−62.85%

Net profit

Net profit growth by window
3YTurned to loss
1YTurned to loss
TTMTurned to loss

Operating cash flow

Operating cash flow growth by window
3Y−64.01%
1Y−61.43%
TTM—

TTM: Reported once a year, so there is no trailing-twelve-month figure.

Operating margin· change in pp

Operating margin growth by window
3Y−23.06 pp
1Y−31.96 pp
TTM−40.09 pp

Revenue by year

Revenue by year, ₹ crore
Mar 2022₹15.45 Cr
Mar 2023₹11.41 Cr
Mar 2024₹12.78 Cr
Mar 2025₹5.94 Cr

Net profit by year

Net profit by year, ₹ crore
Mar 2022₹4.37 Cr
Mar 2023₹1.06 Cr
Mar 2024₹4.15 Cr
Mar 2025−₹0.04 Cr

Quarterly Results

₹ Cr

Results for the period ended Mar 2026 were due by 30 May 2026 and are not in this table yet.

542918 quarterly results, ₹ crore
Particulars Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Sales
5.09
1.55
2.43
2.3
3.79
4.6
1.98
1.95
1.59
1.11
0.87
0.66
1.12
Expenses
2.83
2.31
1.92
1.97
1.59
1.55
1.76
1.74
1.12
1.12
0.74
1.07
0.87
Operating Profit
2.26
−0.76
0.51
0.33
2.2
3.05
0.22
0.21
0.47
−0.01
0.13
−0.41
0.25
OPM %
44.4%
−49.03%
20.99%
14.35%
58.05%
66.3%
11.11%
10.77%
29.56%
−0.9%
14.94%
−62.12%
22.32%
Other Income
0.17
0.18
0.14
0.15
0.19
0.18
0.19
0.17
0.16
−0.24
0.15
0.09
0.09
Interest
0.12
0.11
0.12
0.11
0.14
0.1
0.14
0.12
0.12
0.13
0.09
0.12
0.15
Depreciation
0.14
0.12
0.13
0.13
0.16
0.11
0.12
0.12
0.12
0.27
0.11
0.11
0.11
PBT
2.17
−0.81
0.4
0.24
2.09
3.02
0.15
0.14
0.39
−0.65
0.08
−0.55
0.08
Tax %
13.82%
17.28%
35%
16.67%
25.36%
29.47%
40%
14.29%
10.26%
−7.69%
37.5%
−7.27%
−37.5%
Net Profit
1.86
−0.95
0.26
0.2
1.55
2.13
0.09
0.12
0.35
−0.6
0.05
−0.51
0.1
EPS (₹)
1.8
−0.92
0.25
0.19
1.5
2.06
0.09
0.12
0.34
−0.58
0.05
−0.49
0.1

Profit & Loss

₹ Cr
542918 profit and loss, annual, ₹ crore
Particulars Mar 2022Mar 2023Mar 2024Mar 2025TTM
Sales
15.45
11.41
12.78
5.94
3.76
Expenses
9.39
9.56
6.63
4.98
3.8
Operating Profit
6.06
1.85
6.15
0.96
−0.04
OPM %
39.22%
16.21%
48.12%
16.16%
−1.06%
Other Income
0.51
0.69
0.67
0.26
0.09
Interest
0.39
0.45
0.54
0.55
0.49
Depreciation
0.33
0.5
0.53
0.63
0.6
PBT
5.85
1.59
5.75
0.04
−1.04
Tax %
25.3%
33.33%
27.65%
200%
—
Net Profit
4.37
1.06
4.15
−0.04
−0.96
EPS (₹)
4.23
1.02
4.01
−0.04
−0.92
Div. Payout %
0%
0%
0%
0%
—

Balance Sheet

₹ Cr
542918 balance sheet, annual, ₹ crore
Particulars Mar 2022Mar 2023Mar 2024Mar 2025Sep 2025
Equity Capital
10.34
10.34
10.34
10.34
10.34
Reserves
3.69
4.78
8.93
8.89
8.43
Borrowings
2.03
4.57
4.88
5.84
5.73
Other Liabilities
7
8.56
8.48
10.86
9.65
Total Liabilities
23.06
28.25
32.63
35.93
34.15
Fixed Assets
3.5
4.62
5.07
4.45
4.22
CWIP
0.12
0.14
0.14
0.14
0.14
Investments
0
0
0
0
0
Other Assets
19.44
23.49
27.42
31.34
29.79
Total Assets
23.06
28.25
32.63
35.93
34.15

Cash Flow

₹ Cr
542918 cash flow, annual, ₹ crore
Particulars Mar 2022Mar 2023Mar 2024Mar 2025
Operating
5.79
2.22
0.7
0.27
Investing
−4.12
−0.94
−0.32
0.25
Financing
0.67
−0.37
−0.16
0.45
Net Cash Flow
2.34
0.91
0.22
0.97
Free Cash Flow
4.83
0.59
−0.28
0.26
CFO/EBITDA
107
121
12
31

Ratios

542918 financial ratios, annual
Particulars Mar 2022Mar 2023Mar 2024Mar 2025
Debtor Days
42.05
104
137
374
Cash Conversion Cycle
42.05
104
137
374
Working Capital Days
−31.66
−162
−81.4
−75.58
ROCE %
—
11.41%
28.7%
2.4%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Gian Lifecare insights

52 extracted metrics across FY19–FY26.

Shareholding Pattern

As of Mar 2026

  • Public 53.47%
  • Promoters 30.17%
  • Others 16.35%
  • Government 0.01%

65.08% of promoter holding pledged as of 14 Oct 2026

Change vs previous quarter

Documents

Frequently Asked Questions about Gian Lifecare

What does Gian Lifecare Ltd do?
Incorporated in 2018, Gian Lifecare Ltd is in the business of independent diagnostic/pathological laboratories
Where is Gian Lifecare Ltd (GIANLIFE) listed?
Gian Lifecare Ltd trades under code 542918 on the BSE.
Which sector does Gian Lifecare Ltd belong to?
Gian Lifecare Ltd is classified under the Healthcare Services sector, in the Healthcare Service Provider industry.
What is the 52-week high and low of Gian Lifecare Ltd?
Over the last 52 weeks Gian Lifecare Ltd has traded between ₹3.93 and ₹13.23 as of 4 Nov 2026.
What is the Return on Equity (ROE) of Gian Lifecare Ltd?
Gian Lifecare Ltd reported a return on equity of -0.21%. Its debt-to-equity ratio is 0.31.

Company Information

Incorporated in 2018, Gian Lifecare Ltd is in the business of independent diagnostic/pathological laboratories

Website gianpathlabs.com
Listed 13 Jan 2020
Face Value ₹10

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/542918.md for Gian Lifecare Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More

More Hospital & Healthcare Services stocks → FII DII DataStock ScreenerNifty 50 HeatmapF&O Ban ListFII and DII flows, month by monthHow Tapetide Scores changed, month by monthStocks mutual funds are buying, month by month